摘要
目的探讨尤瑞克林治疗急性脑梗死的临床疗效和不良反应。方法 112例急性脑梗死患者随机分为2组,尤瑞克林治疗组56例,对照组56例。通过神经功能缺损评分判断疗效,观察治疗后神经功能改善情况。结果尤瑞克林治疗组有效率为89.29%,对照组有效率为71.43%,治疗14 d后尤瑞克林治疗组有效率显著高于对照组,2组比较有显著性差异(P<0.05)。2组均未发现严重的不良反应。结论尤瑞克林治疗急性脑梗死安全有效。
Objective To evaluate the effects and adverse reactions of Urinary Kallidinogenase on treatment of acute cerebral infarction.Methods 112 patients suffered with acute cerebral infarction were divided into Urinary Kallidinogenase group and control group.Each group had 56 patients.Effects were judged according neural function scores.Changes of neural function were studied.Results The efficient rate of Urinary Kallidinogenase group was 89.29%.The efficient rate of control group was 71.43%.The efficient rate of Urinary Kallidinogenase group was significantly higher than that of control group after 14 days of treatment.There were significantly differences between them（P0.05）.The apparent adverse actions were not found in two groups.Conclusion Urinary Kallidinogenase was effective and safe in treatment of the patients with acute cerebral infarction.
出处
《基层医学论坛》
2011年第1期25-26,共2页
The Medical Forum
关键词
急性脑梗死
尤瑞克林
疗效
不良反应
Acute cerebral infarction Urinary Kallidinogenas Effect Adverse reactions
